Virpax Pharmaceuticals, Inc. (VRPX)
OTCMKTS
· Delayed Price · Currency is USD
0.0111
0.00 (0.00%)
At close: Mar 3, 2026
Virpax Pharmaceuticals Market Cap
Virpax Pharmaceuticals has a market cap or net worth of $13.79 thousand as of March 6, 2026. Its market cap has decreased by -99.72% in one year.
Market Cap
13.79K
Enterprise Value
-1.50M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since February 17, 2021, Virpax Pharmaceuticals's market cap has decreased from 32.29M to 13.79K, a decrease of -99.96%. That is a compound annual growth rate of -78.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 13.79K | - |
| Dec 31, 2025 | 13.79K | -99.55% |
| Dec 31, 2024 | 3.07M | -18.06% |
| Dec 29, 2023 | 3.75M | -48.56% |
| Dec 30, 2022 | 7.29M | -81.86% |
| Dec 31, 2021 | 40.18M | 24.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Q BioMed | 14.51K |
| Regenicin | 15.35K |
| ObsEva | 11.72K |
| Scopus BioPharma | 16.83K |
| Biostax | 10.71K |
| Aridis Pharmaceuticals | 10.66K |
| Trevena | 10.64K |
| GeneLink | 10.60K |